4//SEC Filing
EYEGATE PHARMACEUTICALS INC 4
Accession 0001144204-17-012198
$KPRXCIK 0001372514operating
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:25 PM ET
Size
7.4 KB
Accession
0001144204-17-012198
Insider Transaction Report
Form 4
Wirostko Barbara
Chief Medical Officer
Transactions
- Award
Common Stock
2017-02-28$2.59/sh+54,200$140,378→ 209,142 total - Award
Common Stock
2017-02-28$2.60/sh+41,700$108,420→ 41,700 total(indirect: By Spouse)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.55 to $2.70, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.55 to $2.69, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeoperating
Related Parties
1- filerCIK 0001372514
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 5:25 PM ET
- Size
- 7.4 KB